These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 3834613)

  • 1. Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia.
    Kong DS; Yeo SH
    Singapore Med J; 1985 Dec; 26(7):551-5. PubMed ID: 3834613
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluphenazine and flupenthixol decanoate in psychiatric outpatients practice.
    Coufal J; Novotný M
    Act Nerv Super (Praha); 1981 Dec; 23(4):269-71. PubMed ID: 6121439
    [No Abstract]   [Full Text] [Related]  

  • 3. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS; Yeo SH
    Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology.
    Wistedt B; Ranta J
    Acta Psychiatr Scand; 1983 Jun; 67(6):378-88. PubMed ID: 6349256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia.
    Kelly HB; Freeman HL; Banning B; Schiff AA
    Int Pharmacopsychiatry; 1977; 12(1):54-64. PubMed ID: 406212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Pinto R; Bannerjee A; Ghosh N
    Acta Psychiatr Scand; 1979 Oct; 60(4):313-22. PubMed ID: 390972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of the effects of fluphenazine-depot and flupenthixol-depot in the treatment of schizophrenic psychoses].
    Bilikiewicz A; Sep-Kowalikowa B
    Psychiatr Pol; 1976; 10(4):359-66. PubMed ID: 981411
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trial of flupenthixol decanoate in chronic withdrawn schizophrenic patients.
    Vichaiya V
    J Med Assoc Thai; 1980 Apr; 63(4):205-9. PubMed ID: 6991627
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience with depot neuroleptics].
    Arató M; Erdós A
    Orv Hetil; 1979 Apr; 120(17):1015-21. PubMed ID: 372888
    [No Abstract]   [Full Text] [Related]  

  • 10. Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.
    Turbott J; Villiger J; Hunter L
    Aust N Z J Psychiatry; 1987 Sep; 21(3):327-38. PubMed ID: 3435373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flupenthixol decanoate (fluanxol depot) in the treatment of chronic schizophrenic patients.
    Haider I
    J Pak Med Assoc; 1985 Sep; 35(9):286-9. PubMed ID: 3934417
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative trial of the decanoates of flupenthixol and fluphenazine.
    Hamilton M; Card IR; Wallis GG; Mahmoud MR
    Psychopharmacology (Berl); 1979 Aug; 64(2):225-9. PubMed ID: 115046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.
    Knights A; Okasha MS; Salih MA; Hirsch SR
    Br J Psychiatry; 1979 Dec; 135():515-23. PubMed ID: 394794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flupenthixol versus combined fluphenazine-nortriptyline in depressive illness.
    Conway JF
    Practitioner; 1981 Mar; 225(1353):400-4. PubMed ID: 7022433
    [No Abstract]   [Full Text] [Related]  

  • 15. Depot fluphenazine and flupenthixol in the treatment of stabilized schizophrenics. A double-blind comparative trial.
    Chowdhury ME; Chacon C
    Compr Psychiatry; 1980; 21(2):135-9. PubMed ID: 6991205
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptic serum levels measured by radioreceptor assay in patients receiving intramuscular depot neuroleptics. Some preliminary findings.
    Turbott J; Villiger J; Hunter L
    Br J Psychiatry; 1985 Apr; 146():439-42. PubMed ID: 4016448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flupentixol and flupentixol decanoate, with special reference to their antipsychotic effect.
    Gottfries CG
    Acta Psychiatr Belg; 1974 Sep; 74(5):507-16. PubMed ID: 4620362
    [No Abstract]   [Full Text] [Related]  

  • 18. Haloperidol decanoate and flupenthixol decanoate in schizophrenia. A long-term double-blind cross-over comparison.
    Eberhard G; Hellbom E
    Acta Psychiatr Scand; 1986 Sep; 74(3):255-62. PubMed ID: 3788652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics.
    Wistedt B; Palmstierna T
    J Clin Psychiatry; 1983 Oct; 44(10):369-71. PubMed ID: 6643398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.
    Wistedt B
    Acta Psychiatr Scand; 1981 Jul; 64(1):65-84. PubMed ID: 7032224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.